Dennis W Choi

This inventor holds 6 USPTO granted patents. Top assignees: Samsung Electronics Co., Ltd., Washington University. Active years: 1998-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis W Choi. Retrieved from https://idiyas.com/inventor/dennis-w-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 33.3

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

4 out of 132,108

Samsung Electronics Co., Ltd.

patents

2 out of 1,381

Washington University

patents

Years Active: 1998-2009

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7511034 - Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses (2009-03-31),

2. 7229988 - Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses (2007-06-12),

3. 6949654 - N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses (2005-09-27),

4. 6815459 - Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses (2004-11-09),

5. 6265443 - Method for treating neuronal injury with carboxyfullerene (2001-07-24),

6. 5789444 - Method of reducing glutamate neurotoxicity with anthranilic acid (1998-08-04),

Title: Dennis W. Choi: Innovator in Therapeutic Compounds

Introduction

Dennis W. Choi is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of therapeutic compounds, particularly in the development of novel dialkylhydroxybenzoic acid derivatives. With a total of 6 patents, his work focuses on addressing medical dysfunctions and diseases related to reactive oxygen species and excess zinc ions.

Latest Patents

Choi's latest patents include innovative dialkylhydroxybenzoic acid derivatives containing metal chelating groups. These compounds are designed for therapeutic use in treating and preventing various medical conditions, including stroke, Parkinson's disease, and Alzheimer's disease. The novel compounds exhibit low toxicity and demonstrate similar or superior lipid peroxidation (LPO) inhibition activity compared to existing references. Additionally, they effectively inhibit cerebral neuronal cell death caused by reactive oxygen species and zinc ions, showcasing neuroprotective effects against ischemic neuronal degeneration.

Career Highlights

Throughout his career, Dennis W. Choi has worked with notable organizations, including Samsung Electronics Co., Ltd. and Washington University. His experience in these institutions has contributed to his expertise in the development of therapeutic innovations.

Collaborations

Choi has collaborated with esteemed colleagues such as Sung-Bo Ko and Eu-Gene Oh. These partnerships have further enhanced his research and development efforts in the field of therapeutic compounds.

Conclusion

Dennis W. Choi's innovative work in the development of therapeutic compounds has the potential to significantly impact the treatment of various medical conditions. His contributions to the field are marked by a commitment to advancing medical science through his patented inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]